Dent Neurologic

J Aubrey Bottoms

Ph.D., ABPP-CN

Dr. Bottoms is a Board Certified Clinical Neuropsychologist and the Director of the Neuropsychology, Behavioral Health, and Wellness division at DENT. She is also well versed in the evaluation of adult and pediatric cognitive and psychiatric symptoms of post-concussion disorder

Dr. Bottoms is located at DENT Tower in Amherst.

Throughout her education and training at the University at Buffalo, Brown, Tulane, and Penn State, she has acquired specialized knowledge of the neuropsychological sequelae of several neurologic disorders including neuro-oncology, memory disorders such as mild cognitive impairment and various dementias, epilepsy, stroke, and multiple sclerosis.

SPECIALITIES

- Memory Disorders
- Neuropsychology
- Post Concussion/Head Injury
- Perinatal Mental Health
- Infertility

Board Certifications​

- Clinical Neuropsychology
- Perinatal Mental Health

Education

Medical / Graduate Education
University at Buffalo

Internship
Brown Medical School

Residency
University at Buffalo School of Medicine & Biomedical Sciences

Fellowship
Neuropsychology; University at Buffalo School of Medicine & Biomedical Sciences

Open Clinical Trials

Alzheimer's

IGC Pharma

IGC PHARMA (Alzheimer’s Disease with Agitation) This is a trial of the safety and efficacy of IGC-AD1 on Agitation in Participants with Dementia due to ...
Read More →
Alzheimer's

ACADIA RADIANT

ACADIA RADIANT (Alzheimer’s Disease Psychosis) In this study, researchers will evaluate ACP-204 in patients with Alzheimer’s Disease Psychosis. Inclusion Criteria:  50 years to 95  years ...
Read More →
Alzheimer's

SUVEN CTP3S1502HT6

SUVEN CTP3S1502HT6 (Alzheimer’s Disease with Agitation) This study will be conducted to evaluate the efficacy, safety, tolerability, and pharmacokinetics of masupirdine compared to placebo for ...
Read More →
Alzheimer's

ADCS BENFO-TEAM

ADCS BENFO-TEAM The purpose of this study is to learn more about the safety, effectiveness and tolerability of the study drug called Benfotiamine which may ...
Read More →
Alzheimer's

ADNI4 Trial

ADNI4 Trial The ADNI4 is multi-center, a non-randomized, natural history, non-treatment study. 1,150 participants will be enrolled across three cohorts: cognitively normal (CN), mild cognitive ...
Read More →

Want to participate in a study?

Fill out the form below and one of our Research Coordinators will be in contact with you as soon as possible. If we currently do not have a study that is currently available for you, we will add you to our database for future studies.

Subscribe To Our Newsletter

Sign up to receive email updates on announcements, new services added, company updates & more!

Call us to schedule an appointment

Our entire team, from customer service to patient providers, is focused on the central mission to deliver superior clinical care, advanced neurodiagnostics, clinical research and education that will assist our patients in maximizing their quality of life. We strive to exceed the expectations of our patients, clinical partnerships and community partners.

Scroll to Top